%0 Journal Article
%B European Journal of Heart Failure
%D 2019
%P 665 - 675
%T A trial to evaluate the effect of the sodium–glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
%V 21